AAAAAA

   
Results: 1-8 |
Results: 8
Association study of schizophrenia with polymorphisms at six candidate genes
Authors: Virgos, C Martorell, L Valero, J Figuera, L Civeira, F Joven, J Labad, A Vilella, E
Citation: C. Virgos et al., Association study of schizophrenia with polymorphisms at six candidate genes, SCHIZOPHR R, 49(1-2), 2001, pp. 65-71
Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrate
Authors: Canudas, J Cenarro, A Civeira, F Garcia-Otin, AL Aristegui, R Diaz, C Masramon, X Sol, JM Hernandez, G Pocovi, M
Citation: J. Canudas et al., Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrate, METABOLISM, 50(4), 2001, pp. 447-450
Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygoussubjects for apo A-I-Zaragoza (L144R)
Authors: Recalde, D Velez-Carrasco, W Civeira, F Cenarro, A Gomez-Coronado, D Ordovas, JM Pocovi, M
Citation: D. Recalde et al., Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygoussubjects for apo A-I-Zaragoza (L144R), ATHEROSCLER, 154(3), 2001, pp. 613-623
Transforming growth factor beta (TGF-beta) in Gaucher's disease. Preliminary results in a group of patients and their relatives (carriers and non-carriers)
Authors: Calvo, JIP Gil, PI Castellano, PG Cabeza, MAT Civeira, F Garcia, SL Pocovi, M
Citation: Jip. Calvo et al., Transforming growth factor beta (TGF-beta) in Gaucher's disease. Preliminary results in a group of patients and their relatives (carriers and non-carriers), MED CLIN, 115(16), 2000, pp. 601-604
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia
Authors: Garcia-Otin, AL Civeira, F Peinado-Onsurbe, J Gonzalvo, C Llobera, M Pocovi, M
Citation: Al. Garcia-otin et al., Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia, EUR J ENDOC, 141(5), 1999, pp. 502-505
Pl(A1/A2) polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia
Authors: Cenarro, A Casao, E Civeira, F Jensen, HK Faergeman, O Pocovi, M
Citation: A. Cenarro et al., Pl(A1/A2) polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia, ATHEROSCLER, 143(1), 1999, pp. 99-104
A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32
Authors: Varret, M Rabes, JP Saint-Jore, B Cenarro, A Marinoni, JC Civeira, F Devillers, M Krempf, M Coulon, M Thiart, R Kotze, MJ Schmidt, H Buzzi, JC Kostner, GM Bertolini, S Pocovi, M Rosa, A Farnier, M Martinez, M Junien, C Boileau, C
Citation: M. Varret et al., A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32, AM J HU GEN, 64(5), 1999, pp. 1378-1387
Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia
Authors: Civeira, F Cenarro, A Ferrando, J Puzo, J Garcia-Otin, AL Mozas, P Pocovi, M
Citation: F. Civeira et al., Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia, AM HEART J, 138(1), 1999, pp. 156-162
Risultati: 1-8 |